Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of ITF2984 in acromegaly
2013-003183-31Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Nov 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of ITF2984 in acromegaly (2 arms), sponsored by Italfarmaco. Primary endpoints: Change in GH levels and Change in IGF-1 levels. Started Nov 2013; status: completed.
02
Drugs
ITF2984
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2013-003183-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003183-31.